After-Market Rally: Evotec (EVO) Surges Following Acquisition Proposal
Fahim Awan
November 15, 2024
The shares of Evotec SE (NASDAQ: EVO) continued to rise sharply on Thursday in response to Halozyme Therapeutics’ purchase proposal. After increasing 12.09% during normal